PetVivo Holdings Inc. (PETV): Price and Financial Metrics
PETV Price/Volume Stats
|Current price||$0.84||52-week high||$3.60|
|Prev. close||$0.81||52-week low||$0.55|
|Day high||$0.87||Avg. volume||25,761|
|50-day MA||$1.43||Dividend yield||N/A|
|200-day MA||$2.13||Market Cap||12.21M|
PETV Stock Price Chart Interactive Chart >
PETV Stock Summary
- PETV's price/sales ratio is 13.85; that's higher than the P/S ratio of 93.17% of US stocks.
- With a year-over-year growth in debt of 340.8%, PETVIVO HOLDINGS INC's debt growth rate surpasses 96.92% of about US stocks.
- As for revenue growth, note that PETV's revenue has grown 475.52% over the past 12 months; that beats the revenue growth of 98.52% of US companies in our set.
- Stocks that are quantitatively similar to PETV, based on their financial statements, market capitalization, and price volatility, are SAI, DOGZ, HAYN, VEEE, and SIBN.
- PETV's SEC filings can be seen here. And to visit PETVIVO HOLDINGS INC's official web site, go to www.petvivo.com.
PETV Valuation Summary
- In comparison to the median Healthcare stock, PETV's price/earnings ratio is 109.05% lower, now standing at -2.2.
- Over the past 111 months, PETV's price/sales ratio has gone NA NA.
Below are key valuation metrics over time for PETV.
PETV Growth Metrics
- The 4 year net income to common stockholders growth rate now stands at 86.59%.
- The year over year revenue growth rate now stands at 818.95%.
- Its 2 year cash and equivalents growth rate is now at 57609.57%.
The table below shows PETV's growth in key financial areas (numbers in millions of US dollars).
|Date||Revenue||Operating Cash Flow||Net Income to Common Stock|
PetVivo Holdings Inc. (PETV) Company Bio
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. It is engaged in the business of translating or adapting human biotech and medical technology into products for commercialization in the veterinary market to treat companion animals such as dogs, horses, cats, and other animals suffering from osteoarthritis and other afflictions. The firm's lead product includes Kush, is an intra-articular injection comprised of patented, gel-like biomaterials that is being commercialized for companion animal osteoarthritis. The company was founded by John Lai and John F. Dolan on March 31, 2009 and is headquartered in Minneapolis, MN.
PETV Latest News Stream
|Loading, please wait...|
PETV Latest Social Stream
View Full PETV Social Stream
Latest PETV News From Around the Web
Below are the latest news stories about PETVIVO HOLDINGS INC that investors may wish to consider to help them evaluate PETV as an investment opportunity.
PetVivo Holdings, Inc. (NASDAQ:PETV) Q2 2024 Earnings Call Transcript November 14, 2023 Operator: Welcome, everyone, to the PetVivo Holdings, Inc., 2024 Fiscal Year Second Quarter Earnings Report. This is November 14, 2023, and I will now hand over to Mr. John Dolan to start the call. John Dolan: Thank you, operator. Greetings, and welcome to […]
Conference call begins at 4:00 p.m. Central time today EDINA, MN, Nov. 14, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the three months ended September 30, 2023 (“second quarter of 2024”). Key highlights from the second quarter of 2024 and through November 14, 2023, include the following: Released clinical study results which d
MINNEAPOLIS, MN, US, Nov. 09, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Tuesday, November 14, 2023 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day. Attendees of the live webcast of the conference call and related earnings release ma
PetVivo Holdings, Inc. Announces Scheduled Presentations by PetVivo Veterinarians at the American Association of Equine Practitioners Convention in San Diego, California
MINNEAPOLIS, MN, US, Nov. 02, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals announced today that two members of PetVivo’s Scientific/Veterinarian Team, Tom Yarbrough, DVM, ACVS and Joseph Manning, DVM, MBA, will present at the American Association of Equine Practitioners (“AAEP”) annual convention to be h
CORRECTION/RETRACTION: New to The Street Announces Four Corporate Interviews on its 525th Show, Airing on the Fox Business Network, Monday, October 30, 2023, at 10:30 PM PT
RETRACTION: Lahontan Gold Corp.’s (OTCQB: LGCXF) (TSXV: LG) ($LGCXF) Interview is not airing on Episode 525; Ignore Previously issued Press Release Retraction: Lahontan Gold Corp.’s (OTCQB: LGCXF) (TSXV: LG) ($LGCXF) Interview is not airing on Episode 525; Ignore Previously issued Press Release Retraction: Lahontan Gold Corp.’s (OTCQB: LGCXF) (TSXV: LG) ($LGCXF) Interview is not airing on Episode 525; Ignore Previously issued Press Release NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) -- FMW Media’s
PETV Price Returns